Bausch Health Companies (BHC) Share-based Compensation (2009 - 2026)

Bausch Health Companies (BHC) reported Share-based Compensation of $34.0 million for Q1 2026, down 20.93% on a YoY basis from $43.0 million in Q1 2025, and down 82.29% sequentially from $192.0 million in Q4 2025.

Bausch Health Companies (BHC) Share-based Compensation (2009 - 2026) Analysis & Trends

Bausch Health Companies (BHC) has 18 years of Share-based Compensation data on file, last reported at $34.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation fell 20.93% year-over-year to $34.0 million; the trailing twelve-month figure through Mar 2026 stood at $207.0 million (up 29.37% YoY), and the FY2025 full-year result was $216.0 million, up 44.0% from the prior year.
  • Share-based Compensation eased to $34.0 million in Q1 2026, from $192.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $192.0 million in Q4 2025 to a low of -$65.0 million in Q3 2025.
  • A 5-year average of $33.1 million and a median of $33.0 million in 2023 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation soared 10800.0% in 2023 and slumped 1400.0% in 2025, its largest moves.
  • Tracing BHC's Share-based Compensation over 5 years: stood at $1.0 million in 2022, then soared by 10800.0% to $109.0 million in 2023, then rose by 16.51% to $127.0 million in 2024, then surged by 51.18% to $192.0 million in 2025, then sank by 82.29% to $34.0 million in 2026.
  • Business Quant data shows BHC's Share-based Compensation at $34.0 million in Q1 2026, $192.0 million in Q4 2025, and -$65.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn 34.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 34.00 Mn
Mar 31, 2026 34.00 Mn
Dec 31, 2025 192.00 Mn
Dec 31, 2025 192.00 Mn
Sep 30, 2025 -65.00 Mn
Sep 30, 2025 -65.00 Mn
Jun 30, 2025 46.00 Mn
Jun 30, 2025 46.00 Mn
Mar 31, 2025 43.00 Mn
Mar 31, 2025 43.00 Mn
Dec 31, 2024 127.00 Mn
Dec 31, 2024 127.00 Mn
Sep 30, 2024 5.00 Mn
Sep 30, 2024 5.00 Mn
Jun 30, 2024 -15.00 Mn
Jun 30, 2024 -15.00 Mn
Mar 31, 2024 33.00 Mn
Mar 31, 2024 33.00 Mn
Dec 31, 2023 109.00 Mn
Dec 31, 2023 109.00 Mn